Skip to main content
. 2017 Jul 18;7:5781. doi: 10.1038/s41598-017-06173-4

Figure 4.

Figure 4

GSK-3β deletion in DG decreases several synapse-associated proteins. (a,b) GSK-3β deletion decreased the levels of multiple pre- and post-synaptic proteins in DG extracts measured by Western blotting and the quantitative analyses (n = 4 each group) (* by unpaired t test, # by multiple t-tests using Sidak-Bonferroin method of GraphPad Prism 6.0). (c,d) GSK-3β deletion in DG excitatory neurons did not change the synapse-associated protein in prefrontal cortex (n = 3 each group) (* by unpaired t test, # by multiple t-tests using Sidak-Bonferroin method of GraphPad Prism 6.0). (e,f) The representative images of the hippocampus by Nissl staining and the densitometric analyses (n = 5–6 each group, unpaired t test). Scale bars, 100 μm. Data were presented as mean ± s.e.m. *P < 0.05, **P < 0.01,***P < 0.001 versus Vector. “#” indicates that the difference is significant analyzed by multiple t-tests. The absence of asterix indicates that the difference is not significant.